Orthopedic Devices Market Size to Reach US$ 86.56 Billion by 2033, Growing at 4.1% CAGR

The global orthopedic devices market was valued at US$ 58.56 billion in 2024 and is expected to climb to US$ 86.56 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.1% between 2025 and 2033, according to DataM Intelligence. Growth is being driven by rising incidences of musculoskeletal disorders, increasing geriatric population, and rapid technological advancements such as robotics and computer-assisted surgery.

Orthopedic devices play a vital role in treating bone, joint, and musculoskeletal disorders stemming from trauma, congenital defects, or degenerative diseases. They are essential for improving mobility, reducing recovery time, and restoring patient quality of life in both surgical and non-surgical cases, particularly following fracture fixations and joint replacements.

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/orthopedic-devices-market?utm_source=OpenPR&utm_campaign=Onkar

Market Drivers and Challenges

Growing Prevalence of Orthopedic Disorders

Rising cases of osteoporosis, arthritis, and related conditions are major market drivers. According to the World Health Organization, rheumatoid arthritis affects approximately 18 million people globally, with women representing nearly 70% of patients, most of whom are over 55 years old. Similarly, in the United States, 10 million people aged 50 and above suffer from hip osteoporosis, while 33.6 million have low bone mass, putting them at risk of future fractures.

Market players are responding with new product innovations. For instance, in February 2023, CurvaFix, Inc. launched its 7.5mm CurvaFix IM Implant, designed to simplify procedures and provide stable fixation in smaller bones.

Technological innovations such as 3D printing, AI-guided surgeries, and biocompatible implants are transforming orthopedic care, improving surgical precision and reducing recovery times.

High Cost of Orthopedic Devices

However, high device costs remain a limiting factor, particularly in low-income markets. The National Institutes of Health reported that implant prices range from US$350 to US$6,370, with per-case costs averaging US$2,817. The high research, manufacturing, and compliance costs of advanced implants can restrict access to affordable orthopedic care, thereby slowing market expansion in developing regions.

Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/orthopedic-devices-market?utm_source=OpenPR&utm_campaign=Onkar

Segment Insights

Orthopedic Braces Segment to Dominate Market Share
The orthopedic braces segment is expected to dominate the market during the forecast period, driven by increasing demand from patients with arthritis, osteoporosis, sports injuries, and post-surgical rehabilitation needs.

According to the International Osteoporosis Foundation, osteoporosis affects 200 million women globally, including one-fifth of women aged 70 and two-thirds aged 90. Developments in material science-such as lightweight composites, ergonomic designs, and patient-specific customization-are boosting comfort and adoption.

For example, in August 2024, Aspen Medical Products introduced the Align Orthosis, a first-of-its-kind prefabricated TLSO, designed in collaboration with spine surgeon Dr. Han Jo Kim to help reduce proximal junctional kyphosis after spinal surgery.

Regional Insights

North America: Largest Market Share

North America leads the global orthopedic devices market, supported by a strong healthcare infrastructure, a large elderly population, and high procedural volumes. The prevalence of osteoarthritis and osteoporosis continues to escalate across the region, stimulating consistent device demand.

According to the Bone Health and Osteoporosis Foundation, around 10 million Americans suffer from osteoporosis, while 44 million more have low bone density, increasing fracture risks. One in two women and one in four men aged 50 or older are projected to experience fractures related to bone weakness in their lifetime.

The region benefits from continuous product innovation and regulatory approvals. In October 2024, Smith+Nephew launched its Legion Hinged Knee (HK) System utilizing Oxinium implant technology, offering superior durability and corrosion resistance compared to traditional materials.

Asia Pacific: Fastest-Growing Market

Asia Pacific is projected to record the fastest growth over the forecast period, propelled by rapid urbanization, healthcare investment, and a rising elderly population. High incidences of osteoporosis and osteoarthritis in countries like India, China, and Japan are driving demand for advanced orthopedic treatments.

The World Health Organization estimates that 30% of postmenopausal women suffer from osteoporosis. In India alone, about 60 million individuals are affected-80% of them women-often encountering symptoms much earlier than patients in Western regions.

Ongoing research collaborations and government investments in health infrastructure are improving access to orthopedic care and technology, further accelerating regional growth.

Purchase This Exclusive Report at Just USD 4364 Only: https://www.datamintelligence.com/buy-now-page?report=orthopedic-devices-market?utm_source=OpenPR&utm_campaign=Onkar

Key Players in the Global Orthopedic Devices Market

Major companies dominating the industry include:

Stryker Corporation

Zimmer Biomet

Synthes Inc. (DePuy Synthes, Johnson & Johnson)

Medtronic plc

Wright Medical Group N.V.

Orthofix Medical Inc.

Integra LifeSciences

Arthrex Inc.

Smith & Nephew plc

Sonoma Orthopaedic Products Inc.

These companies are investing heavily in innovations such as robotics-assisted surgery, biointegrative implants, and minimally invasive procedures to improve orthopedic outcomes.

Recent Developments
March 2024: Stryker launched its Gamma4 Hip Fracture Nailing System across Europe, designed to improve procedural workflow and support complex fracture management.

October 2023: DePuy Synthes received FDA 510(k) clearance for its TriLeap Lower Extremity Anatomic Plating System tailored for internal fixation of bones and fragments in foot and ankle procedures.

August 2023: Enovis Corp. acquired Novastep SAS, expanding its minimally invasive surgical platform for foot and ankle procedures in a €68 million deal.

Contact Us

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com

About Us

DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.

This release was published on openPR.